One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea

Digestive Diseases and Sciences

Volumn 43, Issue 3, 1998, Pages 464-467

  Perng, Chin Lin ^b   Kim, Jong G ^b   El Zimaity, Hala M T ^b   Osato, Michael S ^b   Graham, David Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Clarithromycin; Helicobacter pylori; Lansoprazole; Metronidazole; Triple therapy

Indexed keywords

CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; DIARRHEA; DRUG MIXTURE; DRUG TOLERABILITY; DUODENUM ULCER; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PRURITUS; STOMACH ULCER; TREATMENT OUTCOME; VOMITING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KOREA; MALE; METRONIDAZOLE; OMEPRAZOLE; PEPTIC ULCER; TIME FACTORS;

EID: 0031959445     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018886318740     Document Type: Article

References (30)

1. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69, 1994
2. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T: The role of infectious agents in peptic ulcer disease. Gastroenterol Int 6:76-89, 1993
3. Graham DY, Go MF: Helicobacter pylori: Current status. Gastroenterology 105:279-282, 1993
4. van der Hulst RWM, Keller JJ, Rauws EA, Tytgat GNJ: Treatment of Helicobacter pylori infection in humans: A review of the world literature. Helicobacter 1:6-19, 1996
5. Graham DY: A reliable cure for Helicobacter pylori infection? Gut 37:154-156, 1995
6. Graham DY, de Boer WA, Tytgat GN: Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 91:1072-1076, 1996
7. Graham DY: Determinants of antimicrobial effectiveness in H. pylori gastritis. In RH Hunt, GNJ Tytgat (eds). Helicobacter pylori: Basic Mechanisms to Clinical Cure. Dordrecht, Kluwer Academic Publishers, 1994, pp 531-537
8. de Boer WA, Tytgat GN: How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur J Gastroenterol Hepatol 8:709-716, 1996
9. Hunt RH: Hp and pH: implications for the eradication of Helicobacter pylori. Scand J Gastroenterol Suppl 196:12-16, 1993
10. Graham DY: Clarithromycin for treatment of Helicobacter pylori infections. Eur J Gastroenterol Hepatol 7(suppl 1):S55-S58, 1995
11. Ozmen MM, Johnson CD: Is short-term triple therapy with lansoprazole, clarithromycin, and metronidazole a definitive answer for Helicobacter pylori eradication? Am J Gastroenterol 90:1542-1543, 1995
12. Schwartz H, Krause R, Siepman N, et al: Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report. Helicobacter 1:251-255, 1996
13. Kihira K, Kimura K, Satoh K, et al: Effect of 1-week triple therapy for Helicobacter pylori infection with lansoprazole or ranitidine and clarithromycin and metronidazole. Gastroenterology 110:A154, 1996
14. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H: One week low-dose triple therapy for eradication of H. pylori: A large multicentre, randomised trial. Gastroenterology 110:A198, 1996
15. Pryce DI, Harris AW, Gabe SM, et al: One week of lansoprazole, clarithromycin and metronidazole eradicates Helicobacter pylori. Gastroenterology 110:A235, 1996
16. Chey WD, Fisher L, Elta GH, et al: One week, bid therapy for H. pylori: A randomized comparison of two strategies. Gastroenterology 112:A87, 1997
17. Franceschi M, Pilotto A, Bozzola L, Mario FD, Buda A, Valerio G: Lansoprazole, clarithromycin and/or amoxicillin and metronidazole for one-week to cure Helicobacter pylori infection in the elderly. Gastroenterology 112:A118, 1997
18. Moayyedi P, Langworthy H, Tompkins DS, Mapstone N, Chalmers DM, Axon ATR: The optimum 5 day therapy against Helicobacter pylori. Gastroenterology 112:A223, 1997
19. Malfertheiner P, Megraud F, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, Forman D, Gasbarrini G, Jaup B, Misiewicz JJ, Pajares J, Quina M, Rauws E: Current European concepts in the management of Helicobacter pylori infection -the Maastricht Consensus Report. The European Helicobacter pylori study group (EHPSG). Eur J Gastroenterol Hepatol 9:1-2, 1997
20. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 333:984-991, 1995
21. Soll AH: Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 275:622-629, 1996
22. Bazzoli F: Italian omeprazole triple therapy - a 1-week regimen. Scand J Gastroenterol Suppl 215:118, 1998
23. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, Sottili S, Roda A, Roda E: Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 6:773-777, 1994
24. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 35:490-496, 1991
25. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M: Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies. J Clin Pathol 41:207-210, 1988
26. Megraud F, Lehn N, Lind T: The MACH 2 study. Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 112:A212, 1997
27. Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63:584-592, 1972
28. Siurala M, Varis K, Wiljasalo M: Studies of patients with atrophic gastritis: A 10-15-year follow-up. Scand J Gastroenterol 1:40-48, 1966
29. Siurala M, Salmi HJ: Long-term follow-up of subjects with superficial gastritis or a normal gastric mucosa. Scand J Gastroenterol 6:459-463, 1971
30. Ihamaki T, Saukkonen M, Siurala M: Long-term observation of subjects with normal mucosa and with superficial gastritis: Results of 23-27 years' follow-up examinations. Scand J Gastroenterol 13:771-715, 1978